Bladder Cancer - Study explores long-term outcomes and costs of non-muscle invasive bladder cancer
Can't see this email? View it online
   
  Bladder Cancer  
  The latest bladder cancer news from News Medical  
 Study: Targeted therapy prolongs survival in patients with advanced bladder cancerStudy: Targeted therapy prolongs survival in patients with advanced bladder cancer
 
In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin (EV) significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.
 
   Study explores long-term outcomes and costs of non-muscle invasive bladder cancerStudy explores long-term outcomes and costs of non-muscle invasive bladder cancer
 
A new research study leveraging a database from the largest equal access health system in the US, the Department of Veteran Affairs, offers insight into the outcome of specific treatment patterns for advanced bladder cancer patients.
 
   A new way to predict positive outcomes of immunotherapy in patients with bladder cancerA new way to predict positive outcomes of immunotherapy in patients with bladder cancer
 
Researchers have detected and validated groups of genes linked to immunotherapy resistance in patients with metastatic urothelial cancer of the bladder.
 
   UroCAD assay shows better sensitivity than urine cytology in detecting bladder cancerUroCAD assay shows better sensitivity than urine cytology in detecting bladder cancer
 
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better sensitivity and similar specificity in detecting urothelial carcinoma compared with urine cytology.
 
   Study: Cigarette smoking is linked to worse outcomes in patients treated for bladder cancerStudy: Cigarette smoking is linked to worse outcomes in patients treated for bladder cancer
 
Patients treated for bladder cancer with a surgery known as radical cystectomy have worse outcomes if they are smokers, according to a systematic review and meta-analysis by Keck Medicine of USC. The study appeared in The Journal of Urology.